Concepedia

Shigeo Matsuda

SM

Statistics

Publications

45

Citations

4.8K

H-Index

32

Active since

1996

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Scripps Research Institute

Vanderbilt University

Kyoto University

Encana (Canada)

Shigeo Matsuda is an author at Alnylam Pharmaceuticals (United States) specializing in molecular biology, life sciences, and rna interference.

Publications per year

1996–2024

45

Publications

45

Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**

Muthusamy Jayaraman, Steven M. Ansell, Barbara L. Mui et al. · Angewandte Chemie International Edition · 2012 · 1.2K citations · Full text

, , +17

Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics

Martin A. Maier, Muthusamy Jayaraman, Shigeo Matsuda et al. · Molecular Therapy · 2013 · 619 citations · Full text

, , +17

Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates

Christopher R. Brown, Swati Gupta, June Qin et al. · Nucleic Acids Research · 2020 · 277 citations · Full text

, , +17

Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates

Kirk Brown, Jayaprakash K. Nair, Maja M. Janas et al. · Nature Biotechnology · 2022 · 245 citations

, , +16

siRNA Conjugates Carrying Sequentially Assembled Trivalent <i>N-</i>Acetylgalactosamine Linked Through Nucleosides Elicit Robust Gene Silencing <i>In Vivo</i> in Hepatocytes

Shigeo Matsuda, Kristofer Keiser, Jayaprakash K. Nair et al. · ACS Chemical Biology · 2015 · 213 citations

, , +17

1–5 of 45